THE ULTIMATE EVOLUTION OF CONTROLLED ENVIRONMENT AGRICUTURE
No Single Solution Delivers Like PharmPods
CULTIVATION CONTAINER SYSTEMS
The explosive growth in organic produce and the recent meteoric rise in popularity of the local food movement are a direct result of the nutrient depleted, pesticide laden food on America's grocery store shelves and the detrimental health issues resulting from the same.
FusionPharm's primary focus is to further develop the company's patent pending line of cultivation containers. FusionPharm is the creator and manufacturer of these cultivation container system. They are constructed of standard ISO steel shipping containers that are repurposed for use in indoor plant cultivation. Based on the concept of Controlled Environment Agriculture (CEA) used extensively in greenhouse cultivation for decades, the PharmPod cultivation container is evolving the arena of the Controlled Environment Agriculture (CEA) concept.
Stackable, scalable, secure, durable and clean, these containers allows FusionPharm the ability to foster an environment in the agriculture industry that makes vertical farming economically viable through it's patent pending PharmPlex cultivation centers. Through use of these containers, stacked in an urban warehouse, the PharmPlex maximizes the containers systems scalability and creates unprecedented efficiencies in growth, energy efficiency and space efficiency for cultivation within an urban real estate footprint. Located in the heart of cities and nearest the nation's population centers, the PharmPlex cultivation centers will produce the finest possible produce, picked fresh and ripe and transported less than 100 miles to the final destination.
FusionPharm is piloting its first PharmPlex cultivation center in Denver, Colorado and has partnered with Circle Fresh Farms to provide the agriculture expertise and distribution network for the produce that will be produced. Circle Fresh Farms is the largest producer of organic tomatoes, cucumbers and leafy green vegetables for Whole Foods in Colorado. Circle Fresh Farm's produce is sold in national chains and local supermarkets under the Circle Fresh Farms® brand name. Circle Fresh Farms produce is easily recognized by its
vine-ripe, consistently superior taste, texture and appearance.
URBAN-BASED GROWING, HARVESTING AND DISTRIBUTION
Our PharmPlex cultivation center concept is simple, yet revolutionary - grow and harvest your vegetables and fruits in a faster amount of time, then distribute them over a shorter distance, as compared to traditional farming methods.
Utilizing multiple, stackable cultivation containers growing containers in an urban warehouse setting, our PharmPlex cultivation centers create unprecedented efficiencies in growth, reduced energy use and a smaller real estate footprint. Our PharmPlex centers are designed to be located within the heart of cities, nearest their population centers, to deliver the freshest and finest produce within 100 miles from where they are grown.
FusionPharm is piloting its first PharmPlex cultivation center in Denver, Colorado and has partnered with Circle Fresh Farms - whose produce is recognized for its vine-ripe, consistently superior taste, texture and appearance - to provide the agricultural expertise and distribution network for the produce that will be grown. Circle Fresh Farms is the largest producer of organic tomatoes, cucumbers and leafy green vegetables for Whole Foods in Colorado, and their produce is sold in national chains and local supermarket under that same name.
FSPM Security Details
| || || |
FSPM Security Details
|Market Value1 ||$2,798,757 ||a/o Apr 24, 2013 |
|Shares Outstanding ||5,202,150 ||a/o Apr 01, 2013 |
|Float ||2,234,173 ||a/o Apr 01, 2013 || || |
|Authorized Shares ||495,000,000 ||a/o Apr 01, 2013 || || |
| || || |
| || || |
| || |
|Shareholders of Record ||872 ||a/o Dec 31, 2012 |
| || |
Outside News Sources
» More Headlines for FSPM
- http://www.thestreet.com/_yahoo/story/12442153/1/the-garden-state-goes-green-with-medicinal-marijuana.html?cm_ven=YAHOOV&cm_cat=FREE&cm_ite=NA"; rel="nofollow">[video] The Garden State Goes Green With Medicinal Marijuanaat TheStreet(Wed, Feb 26)
FusionPharm Completes $1million FundingGlobeNewswire(Tue, Feb 25)
FusionPharm doubles production capacityGlobeNewswire(Thu, Feb 13)
FusionPharm completes first sale and financing in Massachusetts Cannabis MarketGlobeNewswire(Tue, Feb 11)
FusionPharm and GrowLife Expand Relationship to Create New Co-Branded Line of Innovative Hydroponic ProductsGlobeNewswire(Tue, Feb 4)
; rel="nofollow">Capitalizing On Cannabis: Marijuana Investing Moves To Main Streetat Seeking Alpha(Mon, Feb 3)
FusionPharm CEO interview on iCannabis RadioGlobeNewswire(Tue, Jan 21)
FUSION PHARM, INC. FinancialsEDGAR Online Financials(Sat, Jan 18)
FusionPharm posts 38% revenue growthGlobeNewswire(Wed, Jan 15)
; rel="nofollow">Capitalizing On Cannabis: Key Considerations For Cannabis Stock Investorsat Seeking Alpha(Mon, Jan 13)
FusionPharm Completes First Order from GrowLifeAccesswire(Thu, Aug 8)
GrowLife and FusionPharm Announce Collaboration Agreement for Equipment Supply and Co-MarketingPR Newswire(Mon, Aug 5)
Meadpoint Completes First California SaleAccesswire(Mon, Jul 29)
FUSIONPHARM offers guaranteed financing to licensed cannabis industry operatorsPR Newswire(Tue, May 14)
; rel="nofollow">Intro To Pot Stocks: Plenty Of Risks Mixed With Large Potential Rewardsat Seeking Alpha(Tue, May 7)
| || |
| || |
| || |
CEO : SCOTT DITTMAN'S INTERVIEWS FusionPharm is targeting the $26 billion organic food industry as a "local source" producer of leafy greens and specialty herbs.
UNITED STATES OF AMERICA
SECURITIES AND EXCHANGE COMMISSION
SECURITIES EXCHANGE ACT OF 1934
Release No. 72177 / May 16, 2014
The Securities and Exchange Commission (“Commission”) announced the temporary
suspension, pursuant to Section 12(k) of the Securities Exchange Act of 1934 (the “Exchange
Act”), of trading in the securities of FusionPharm, Inc. (“FusionPharm”) of Denver, Colorado, at
9:30 a.m. EDT on May 16, 2014, and terminating at 11:59 p.m. EDT on May 30, 2014.
The Commission temporarily suspended trading in the securities of FusionPharm due to a lack of
current and accurate information about the company because of questions that have been raised
about the accuracy and adequacy of publicly disseminated information concerning, among other
things: (1) the company’s assets; (2) the company’s revenues; (3) the company’s financial
statements; (4) the company’s business transactions; and (5) the company’s current financial
condition. This order was entered pursuant to Section 12(k) of the Exchange Act.
The Commission cautions broker-dealers, shareholders, and prospective purchasers that they
should carefully consider the foregoing information along with all other currently available
information and any information subsequently issued by the company.
Further, brokers and dealers should be alert to the fact that, pursuant to Rule 15c2-11 under the
Exchange Act, at the termination of the trading suspension, no quotation may be entered unless
and until they have strictly complied with all of the provisions of the rule. If any broker or dealer
has any questions as to whether or not he has complied with the rule, he should not enter any
quotation but immediately contact the staff in the Division of Trading and Markets, Office of
Interpretation and Guidance, at (202) 551-5777. If any broker or dealer is uncertain as to what is
required by Rule 15c2-11, he should refrain from entering quotations relating to FusionPharm’s
securities until such time as he has familiarized himself with the rule and is certain that all of its
provisions have been met. If any broker or dealer enters any quotation which is in violation of
the rule, the Commission will consider the need for prompt enforcement action.
If any broker-dealer or other person has any information which may relate to this matter, they
should contact Jay Scoggins at (303) 844-1105, Kimberly S. Gre
On May 16, 2014, a search and seizure warrant was executed
at the Company’s offices located in
Commerce City, Colorado as part of an ongoing
investigation of potential securities law
violations. In executing the warrant, federal authorities
seized company records, computers and
approximately $200,000 in funds from one of the Company’s
William Sears has turned "Snitch" or "C.I." (Cooperating Informant) to save his own neck. If you read this link. "Target 1" is William Sears and "Target 2" is Scott Dittman.